-
XOMA Declares Quarterly Preferred Stock Dividends
21 Mar 2024 11:30 GMT
… (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company … shares, each representing 1/1000 of a share of XOMA … 3, 2024. About XOMA Corporation
XOMA is a biotechnology … or biotechnology companies. When XOMA acquires the future economics …
-
XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.
19 Mar 2024 20:05 GMT
… , XOMA commenced a tender offer to acquire all outstanding shares of … total number of outstanding shares, the availability of at … owned subsidiary of XOMA, and all remaining shares not tendered in … demanded appraisal of such shares pursuant to Delaware law, …
-
XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value
08 Mar 2024 12:30 GMT
… NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), the biotech … 2024. About XOMA Corporation
XOMA is a … stock, 984,000 shares issued and outstanding …
Investor contact:
Juliane Snowden
XOMA
+1-646-438-9754
juliane …
-
Biotech Royalty Aggregator XOMA To Acquire Small Cancer-Drug Developer Kinnate Biopharma
16 Feb 2024 18:32 GMT
… developing cancer-targeted therapies. XOMA will commence a tender offer … portfolio,” stated Owen Hughes, XOMA’s CEO.
Kinnate shareholders holding … shareholders agreed to tender their shares in the offer and … KNTE shares are up 11.45% at $2.53, and XOMA stock …
-
Kinnate Biopharma To Be Acquired By XOMA In Cash Deal; Stock Gains
16 Feb 2024 15:58 GMT
… agreed to be acquired by XOMA Corp. (XOMA) in a cash deal … 4 by a subsidiary of XOMA, the company stated.
The transaction … including a majority of Kinnate shares being tendered and availability of …
-
XOMA to buy Kinnate; A pain biotech’s small IPO
16 Feb 2024 15:45 GMT
… Medicines, Sosei Group and Poxel:
XOMA to buy Kinnate Biopharma: The … receive proceeds if XOMA offloads assets. Kinnate’s shares $KNTE were up …
-
Kinnate Biopharma Shares Rise on XOMA Acquisition
16 Feb 2024 15:15 GMT
Shares of Kinnate Biopharma were higher … royalty aggregator XOMA said it would acquire the company.Shares were trading … A wholly owned subsidiary of XOMA will begin a tender offer … acquire all outstanding shares of Kinnate common stock. Shares of XOMA were down …
-
XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right
16 Feb 2024 13:00 GMT
… 2024, to acquire all outstanding shares of Kinnate common stock. … the total number of outstanding shares; the availability of at … a subsidiary of XOMA, and all remaining shares not tendered in … offer for the outstanding shares of Kinnate referenced in …
-
Kinnate Biopharma Inc. Enters into Agreement to be Acquired by XOMA Corporation for Between $2.3352 and $2.5879 Per Share in Cash, Plus One Contingent Value Right per Share
16 Feb 2024 13:00 GMT
… Agreement") whereby XOMA Corporation ("XOMA") will acquire … that the acquisition by XOMA is in the best … of contingent value rights, XOMA’s intention to commence and … ANY DECISION REGARDING TENDERING THEIR SHARES, INCLUDING THE TERMS AND …
-
XOMA Co. (NASDAQ:XOMAO) Short Interest Down 76.9% in January
27 Jan 2024 12:11 GMT
… short interest totalling 1,200 shares, a decrease of 76.9% … 31st total of 5,200 shares. Based on an average daily … ,700 shares, the short-interest ratio is presently 0.2 days.
XOMA … )
Want More Great Investing Ideas?
XOMA Corporation operates as a biotech …